novel
viral
diagnost
tool
need
afford
fast
accur
easi
use
sensit
specif
equival
superior
current
standard
present
viral
diagnost
base
direct
detect
viral
compon
indirect
detect
measur
antibodi
gener
respons
viral
infect
sensit
detect
quantif
still
import
challeng
expect
major
advanc
new
assay
format
synthet
bind
molecul
aptam
compar
tradit
antibodybas
detect
aptam
could
provid
faster
adapt
continu
evolv
viru
strain
higher
discrimin
capac
specif
viru
serotyp
aptam
stabl
easili
modifi
ideal
molecul
detect
chemic
sens
applic
review
use
aptasensor
detect
viral
pathogen
consid
feasibl
aptasensor
becom
standard
devic
pointofcar
diagnost
virus
gener
viral
diagnost
test
divid
two
group
either
develop
detect
viru
directli
indirectli
determin
host
respons
particular
virusspecif
antibodi
induc
upon
infect
indirect
approach
probabl
common
current
diagnost
use
hemodialys
immunocompromis
patient
furthermor
time
lag
viru
infect
abil
detect
specif
antibodi
vari
patient
patient
viru
viru
certain
virus
seroconvers
occur
month
infect
lead
falseneg
result
dramat
consequ
blood
donat
screen
popul
risk
case
virusspecif
antibodi
circul
blood
long
clearanc
viru
infect
result
falseposit
test
limit
avoid
direct
detect
viru
ie
viru
cultiv
antigen
detect
nucleic
acidbas
detect
tabl
viru
cultiv
highli
specif
sensit
laborintens
time
consum
take
day
develop
shellvialcultur
protocol
led
reduct
turnaround
time
result
lowspe
centrifug
procedur
facilit
viral
entri
cell
still
take
least
day
sensit
limit
contrast
viral
antigendetect
method
alreadi
enabl
pointofcar
test
poct
analysi
time
less
h
howev
use
antibodi
costli
test
even
less
sensit
viru
cultiv
high
falseposit
rate
nucleicacid
amplificationbas
detect
current
standard
diagnost
methodolog
mani
hospit
main
advantag
high
sensit
specif
addit
abil
quantifi
number
virus
use
realtim
quantit
pcr
qpcr
isol
nucleic
acid
also
allow
addit
analys
sequenc
gather
inform
sensit
antivir
treatment
origin
viru
import
outbreak
manag
quantif
pathogen
particular
virus
often
use
stage
diseas
activ
prognost
diseas
progress
monitor
efficaci
therapi
prevent
transmiss
exampl
case
hiv
risk
progress
aid
directli
relat
magnitud
viral
load
plasma
addit
number
virus
hivinfect
mother
strongest
risk
factor
transmiss
child
deliveri
anoth
import
exampl
reactiv
cytomegaloviru
cmv
infect
transplant
neg
impact
transplant
outcom
lead
graft
versu
host
diseas
two
exampl
quantit
pcr
method
frequent
use
monitor
viral
load
although
pcr
rel
fast
gener
h
commonli
perform
batch
central
laboratori
done
near
patient
lead
increas
turnaround
time
clinic
relev
qpcr
sensit
viral
detect
question
typic
viral
infect
result
larg
number
viral
particl
quest
therefor
continu
ideal
diagnost
method
afford
fast
accur
easi
use
outsid
central
laboratori
respect
recent
progress
develop
aptasensor
use
aptam
select
molecular
recognit
applic
viralantigen
detect
promis
review
describ
trend
emerg
field
aptasensor
detect
human
viral
pathogen
clinic
sampl
context
current
practic
viru
detect
fig
current
viral
diagnost
assay
still
conduct
central
laboratori
process
batch
import
bottleneck
sinc
pivot
detect
viral
agent
earli
possibl
guid
adequ
treatment
take
prevent
measur
determin
caus
infect
sole
base
clinic
paramet
quit
imposs
treatment
viral
bacteri
infect
differ
significantli
assay
requir
viral
diagnost
sensit
possibl
multiplex
quantif
depend
purpos
applic
case
viral
outbreak
sensit
outweigh
assay
specif
fals
neg
avoid
cost
also
accuraci
rapid
diagnosi
crucial
control
outbreak
recent
exampl
ebola
viru
epidem
west
africa
accur
diagnosi
context
especi
import
sinc
earli
symptom
ebola
viru
diseas
mimic
mani
diseas
commonli
seen
region
includ
symptom
associ
malaria
typhoid
fever
lassa
fever
multiplex
capac
exampl
requir
context
respiratori
infect
commonli
caus
broad
rang
differ
virus
human
immunodefici
viru
hiv
cytomegaloviru
cmv
infect
viral
load
strongli
relat
diseas
clinic
outcom
thu
quantif
import
monitor
treatment
effect
ideal
diagnost
method
fast
accur
easi
use
irrespect
viru
es
assay
requir
poct
could
compli
unmet
need
furthermor
import
assay
compat
larg
varieti
sampl
matric
human
diagnost
nasopharyng
wash
oropharyng
swab
cerebrospin
fluid
stool
urin
blood
design
poct
start
select
target
select
suitabl
viral
target
vital
understand
anatomi
replic
cycl
viru
viru
anatomi
divid
three
part
genet
materi
either
rna
dna
insid
viru
coat
consist
protein
surfac
epitop
essenti
attach
infect
local
virus
lipid
bilay
envelop
protect
protein
coat
viral
diagnost
compon
target
detect
viru
whole
viru
virion
nucleic
acid
andor
viral
fig
envelop
target
hardli
particular
featur
enabl
select
recognit
virusparticl
quantif
difficult
due
lack
proper
standard
problem
recent
allevi
emerg
particlecharacter
method
provid
virion
concentr
calibrationfre
manner
use
resist
puls
techniqu
optic
method
method
use
quantifi
polioviru
one
smallest
virus
nm
diamet
viral
reproduct
virion
produc
host
cell
express
everi
compon
excess
integr
complet
infecti
viru
viral
compon
therefor
far
abund
complet
virion
prefer
target
viral
protein
seem
better
target
sinc
nucleic
acid
rapidli
degrad
clinic
matrix
aptam
short
singlestrand
oligonucleotid
length
nucleotid
adopt
uniqu
sequencedepend
conform
confer
high
affin
specif
bind
wide
rang
nonnucl
acid
target
conform
aptam
reli
basepair
stack
contain
hairpin
bulg
interior
multibranch
loop
also
form
complex
structur
eg
gquadruplex
conform
bind
affin
specif
aptam
similar
mani
case
superior
monoclon
antibodi
aptam
rapidli
reproduc
costeffect
gener
fulli
vitro
select
procedur
ie
systemat
evolut
ligand
exponenti
enrich
selex
sinc
selex
method
depend
live
organ
aptam
select
nonimmunogen
toxic
agent
detect
target
even
nonphysiolog
condit
fast
gener
particularli
attract
anticip
continu
evolv
viru
strain
moreov
use
counterselect
step
selex
crossreact
aptam
elimin
result
aptam
high
discrimin
capac
differ
viru
genotyp
advantag
aptam
attribut
physicalchem
properti
ie
chemic
stabl
wide
rang
ph
storag
condit
temperatur
sensit
organ
solvent
antibodi
aptam
direct
often
termin
label
function
analyt
probe
without
loss
function
orient
label
option
antibodi
limit
lead
decreas
affin
chemic
modif
report
gener
aptam
probe
diagnost
purpos
fulli
resist
nucleas
enzym
import
step
toward
develop
new
gener
viral
diagnost
poct
year
start
selex
procedur
improv
mani
variat
suggest
improv
alter
includ
increas
variabl
target
targetbind
condit
differ
amplif
method
better
partit
nonbind
success
aptamergener
procedur
primarili
determin
appli
select
condit
target
molecul
chosen
select
first
criterion
must
met
though
aptam
recogn
target
even
nonphysiolog
condit
ligandaptam
interact
sensit
prevail
condit
evad
pitfal
composit
select
buffer
close
possibl
matrix
real
life
sampl
diagnost
exploit
aptam
intend
overlook
condit
could
lead
meaningless
select
procedur
ie
isol
aptam
work
ideal
optim
laboratori
condit
inadequ
practic
applic
seemingli
factor
ignor
select
mani
publish
aptam
could
limit
diagnost
potenti
rais
virusspecif
aptam
target
select
either
virusderiv
protein
inactiv
viru
particl
tradit
selex
use
purifi
singl
protein
ligand
select
applic
approach
result
sever
virusselect
aptam
proteinligandbas
selex
method
extens
discuss
recent
review
use
inactiv
viru
particl
target
isol
purif
inactiv
virus
gener
challeng
product
pure
protein
requir
dedic
laboratori
strict
safeti
control
hurdl
might
explain
hand
whole
virusselect
aptam
publish
far
nevertheless
one
earliest
studi
demonstr
feasibl
approach
ie
virusspecif
aptam
select
result
rna
oligonucleotid
capac
discrimin
closelyrel
humaninfluenza
virus
author
incub
rna
pool
apanama
strain
separ
virusselect
oligonucleotid
filtrat
proteinbind
nitrocelluloseacet
membran
increas
specif
isol
oligonucleotid
counter
select
step
also
introduc
use
aaichi
viru
prepar
aptam
obtain
display
affin
hemagglutinin
compar
monoclon
antibodi
distinguish
variou
influenza
virus
procedur
ie
isol
aptam
candid
pass
virusoligonucleotid
mixtur
nitrocellulos
membran
remov
nonspecif
binder
counter
select
relat
viru
effect
appli
rais
dna
rna
aptam
murin
noroviru
human
influenza
virus
respect
although
separ
use
membran
tradit
techniqu
selex
use
corrobor
sever
studi
immobil
target
onto
bead
becom
method
choic
isol
select
oligonucleotid
two
recent
public
report
gener
aptam
magnet
beadimmobil
human
noroviru
strain
influenza
viru
group
appli
virus
captur
monoclon
antibodi
crosslink
paramagnet
bead
target
selex
increas
select
pressur
introduc
counterselect
step
humanstool
suspens
close
rel
target
viru
respect
perform
enzymelink
aptam
sorbent
assay
elasa
demonstr
norovirusspecif
aptam
select
variou
strain
viru
importantli
isol
aptam
could
detect
target
viru
even
clinic
matrix
fece
use
stateoftheart
procedur
influenzaviru
aptam
select
fulli
implement
integr
microfluid
chip
develop
microfluid
brought
appear
selex
chip
recent
year
due
high
speed
low
reagent
need
eas
tune
excel
partit
effici
devic
expect
becom
standard
aptam
select
anoth
beadimmobilizationbas
method
monolex
publish
select
aptam
whole
viru
techniqu
involv
affinitychromatographi
step
oligonucleotid
librari
immobil
vaccinia
viru
follow
subsequ
physic
partit
virusco
resin
pcr
amplif
bound
aptam
contrast
convent
selex
monolex
accomplish
one
step
instead
iter
select
cycl
immobil
target
aptam
select
two
advers
consequ
stringent
counterselect
step
need
screen
oligonucleotid
bind
support
target
immobil
may
lead
shield
desir
epitop
homogen
selex
approach
evad
shortcom
sinc
requir
coupl
target
solid
support
homogen
aptamergener
protocol
domin
capillari
electrophoresisbas
selex
ceselex
modif
ceselex
appli
isol
avian
influenza
virusspecif
aptam
use
purifi
hemagglutinin
protein
target
molecul
convers
method
wholevirusbas
select
yet
demonstr
publish
wholevirusbas
aptamerselect
protocol
highlight
necess
extens
counterselect
step
pertin
virus
matric
prospect
analyt
counter
select
technic
feasibl
ce
success
ceselex
demand
target
molecul
extrem
high
puriti
requir
hard
fulfil
viru
prepar
limit
applic
ceselex
wholeviru
select
recent
uniqu
revers
manner
immobil
method
describ
product
aptam
whole
bovin
viral
diarrhea
viru
bvdv
known
singlestrand
dna
ssdna
get
adsorb
graphen
oxid
go
sheet
desorpt
trigger
conform
chang
ssdna
upon
target
protein
bind
leverag
phenomenon
socal
goselex
invent
appli
success
gener
highlyselect
bvdvspecif
aptam
fig
first
step
select
incub
oligonucleotid
librari
classic
swinefev
viru
follow
addit
go
oligonucleotid
bind
counter
target
adsorb
surfac
go
separ
centrifug
oligonucleotid
bound
counter
target
suspend
bind
buffer
ssdna
recov
go
addit
target
bvdv
amplifi
pcr
follow
five
round
stringent
select
highlyselect
aptam
obtain
use
surfaceplasmon
reson
spr
base
sandwichtyp
assay
recent
whole
rang
virusspecif
aptam
gener
vaccinia
viru
dengu
viru
sever
acut
respiratori
syndrom
sar
hepat
c
human
immunodefici
viru
hiv
appl
stem
pit
viru
bovin
viral
diarrhea
viru
noroviru
rabi
viru
hepat
b
ebola
influenza
use
aptam
aptasensor
often
requir
immobil
aptam
strand
well
label
enabl
detect
due
adapt
recognit
mechan
small
size
aptam
requir
precaut
immobil
surfac
densiti
aptam
monolay
often
critic
depend
target
size
bind
affin
surfaceconfin
aptam
may
influenc
steric
hindranc
fold
interfer
may
ultim
reduc
sensit
gener
one
two
end
aptam
modifi
function
eg
hs
biotin
allow
conveni
coval
attach
differ
materi
transduc
posit
function
handl
seem
affect
sensit
hardli
predict
way
best
posit
depend
aptam
sequenc
often
linker
strand
insert
consist
sever
thymidin
unit
known
exhibit
low
nonspecif
adsorpt
incorpor
recognit
unit
solid
support
diagnost
applic
target
measur
bodili
fluid
contain
vast
number
nucleas
avoid
degrad
broad
rang
minor
modif
oligonucleotid
shown
increas
nucleas
resist
besid
modif
stabil
immobil
extens
rang
molecular
label
attach
rna
dna
aptam
sometim
linker
oligonucleotid
spacer
molecul
reduc
interfer
target
recognit
molecul
normal
use
detect
purpos
includ
fluorophor
quencher
quantum
dot
reliabl
sensit
transduct
aptasensor
pivot
function
mani
way
transduct
vast
major
transform
biorecognit
process
via
physicochem
transduc
measur
electrochem
mass
optic
signal
tabl
give
overview
recent
develop
aptam
aptasensor
context
viral
pathogen
present
field
aptasensor
viral
detect
much
domin
optic
transduct
eg
base
measur
fluoresc
well
colorimetr
refract
index
relat
chang
fluoresc
detect
work
signalon
signaloff
mechan
reli
respect
increas
decreas
fluoresc
signal
upon
target
bind
signalon
method
much
sensit
fluorophor
also
sensit
environment
chang
method
test
aqueou
buffer
instead
bodili
fluid
nucleicacid
aptam
offer
inher
fluoresc
transduct
mechan
hardli
possibl
antibodybas
recognit
use
molecular
beacon
aptam
shown
rnaaptam
beacon
made
specif
detect
presenc
tat
protein
peptid
ie
enabl
discrimin
rnabind
protein
use
split
oligom
deriv
rna
tat
aptam
presenc
target
two
oligom
form
duplex
lead
remov
fluorophor
vicin
quencher
consequ
increas
fluoresc
signal
onestep
quantif
virus
success
similar
fluoresc
resonanceenergi
transfer
fret
base
competit
bind
assay
demonstr
determin
hepat
b
viru
fret
donor
coval
attach
antihepat
b
viru
rna
aptam
label
hepat
b
viru
fret
acceptor
presenc
unlabel
target
remov
acceptor
vicin
donor
lead
shift
fluoresc
dosedepend
fashion
enabl
determin
target
concentr
method
appear
sensit
abbott
architect
assay
current
method
hepat
b
quantif
need
label
aptam
signific
costincreas
factor
assay
avoid
extern
signal
report
use
relev
exampl
system
base
use
thiazol
orang
fluoresc
upon
bind
gquadruplex
stabil
targetaptam
interact
enabl
fluoresc
detect
influenza
viru
human
serum
use
guaninerich
aptam
recombin
hemagglutinin
protein
viru
addit
sensit
enhanc
obtain
immobil
aptam
ag
coreshel
nanoparticl
act
metalenhanc
fluoresc
mef
sens
platform
thu
limit
detect
lod
ng
ml
protein
target
could
realiz
assay
min
human
serum
dramat
lower
lod
report
ahn
et
al
microarraybas
fluoresc
detect
though
test
less
demand
matrix
develop
rna
aptam
ctermin
region
sar
coronaviru
sarscov
nucleocapsid
protein
kd
nm
implement
aptamerantibodi
hybrid
immunoassay
ie
chemiluminesc
immunosorb
assay
clisa
nanoarray
aptam
chip
clisa
lod
pgml
purifi
nucleocapsid
protein
similar
elisa
nanoarray
aptam
chip
even
lower
lod
pgml
howev
detect
sarscov
nucleocapsid
still
antibodi
mediat
similar
immunosorb
assay
publish
rel
long
assay
time
due
requir
label
made
assay
less
suitabl
poct
spr
also
often
examin
poct
potenti
recent
bai
et
al
develop
portabl
biosensor
base
spr
detect
avian
influenza
viru
aiv
poultri
swab
use
hemagglutinin
target
select
dna
aptam
subsequ
use
whole
aiv
particl
target
increas
specif
dna
aptam
lowest
kd
nm
select
subsequ
immobil
gold
surfac
sensor
detect
rang
poultryswab
sampl
contain
viru
hemagglutin
unit
hau
spr
biosensor
specif
aiv
display
low
signal
expos
six
nontarget
aiv
great
advantag
portabl
aptasensor
compar
convent
method
rel
short
detect
time
h
time
system
labelfre
lack
use
antibodi
reus
time
aptam
select
perform
obtain
number
aptam
bind
differ
protein
epitop
viru
enabl
use
sandwich
assay
increas
sensit
select
viru
detect
park
et
al
shown
pair
aptam
select
whole
bovin
viral
diarrhea
viru
type
sensit
spr
detect
enhanc
decor
surfacebound
viru
subsequ
step
secondari
goldnanoparticl
aunp
label
aptam
ser
also
use
labelfre
optic
method
identif
influenza
virus
detect
bind
nucleoprotein
differ
influenza
b
strain
polyval
antiinfluenza
dna
aptam
incub
three
differ
influenza
strain
auruguay
abrisban
bbrisban
alter
spectrum
distinguish
way
due
conform
chang
aptam
common
issu
mani
optic
sens
methodolog
fret
solgel
chip
mef
affin
ce
laserinduc
fluoresc
celif
biolay
interferometri
bli
depend
sensit
bulki
expens
readout
equip
contrast
colorimetr
aptasensor
lateralflow
assay
would
suitabl
poct
evalu
even
nake
eye
appar
aspect
far
receiv
less
attent
term
use
aptam
select
recognit
reagent
colorimetr
detect
base
aggreg
aptamermodifi
aunp
virion
explor
influenza
viru
aggreg
combin
simpl
centrifug
step
enhanc
visual
percept
precipit
aggreg
howev
lod
obtain
vpml
upper
end
relev
viru
load
publish
work
applic
lateralflow
assay
aptamerbas
reagent
also
scarc
report
avail
sole
involv
measur
viral
coat
protein
exampl
wang
et
al
publish
competit
lateralflow
assay
amount
goldconjug
aptam
bound
complementari
dna
test
line
reduc
competit
bind
target
hepat
c
core
antigen
test
lod
pgml
use
scanner
detect
pgml
nake
eye
massdepend
transduct
offer
labelfre
detect
transduc
modifi
select
receptor
massbas
transduct
realiz
use
quartzcryst
microbal
qcm
aptamermodifi
surfac
well
micromechan
sensor
base
reson
microcantilev
applic
qcm
aptamerbas
detect
viral
compon
initi
minuni
et
al
detect
tat
protein
comparison
tat
antibodybas
sensor
result
higher
sensit
aptamerbas
sensor
good
select
type
sensor
neither
adequ
detect
tat
protein
real
sampl
wang
li
took
advantag
uniqu
properti
aptam
antibodi
creat
hydrogelbas
qcm
aptasensor
detect
aiv
expos
viral
antigen
ha
aiv
aptam
chang
conform
disrupt
hybrid
bind
viru
qcm
sensor
detect
decreas
fundament
frequenc
quartz
crystal
result
mass
chang
surfac
reson
propos
construct
hydrogelbas
qcm
aptasensor
prove
lod
order
magnitud
lower
convent
qcm
setup
hau
compar
hau
respect
result
made
sensor
promis
poct
suitabl
rapid
test
min
easi
use
sensit
specif
diagnosi
aiv
abl
compet
rtpcr
term
sensit
micromechan
sens
use
reson
cantilev
appli
detect
hepat
c
viru
hcv
sensit
pgml
method
exploit
immobil
aptam
top
surfac
cantilev
steric
crowd
upon
bind
bulkier
target
latter
creat
surfac
stress
detect
chang
reson
frequenc
microcantilev
small
size
microcantilev
made
easi
facilit
highthroughput
multiplex
screen
advantag
poct
multipl
virus
howev
due
suscept
environment
condit
measur
microcantilev
complet
execut
temperatureand
rel
humiditycontrol
chamber
hinder
use
poct
labelfre
electrochem
transduc
act
upon
format
aptamertargetrecognit
complex
conduct
semiconduct
surfac
chang
resist
capacit
solutionelectrod
interfac
easi
miniatur
offer
lod
femtomolar
micromolar
rang
sensit
devic
increas
electrod
separ
decreas
nanochip
multipl
aptam
sensor
would
enabl
simultan
detect
sever
virus
drawback
decreas
recognit
interfac
reduc
number
aptam
lead
reduc
dynam
rang
assay
howev
viral
diagnost
inform
viral
load
alway
essenti
assign
proper
treatment
exampl
electrochem
sensor
labelfre
viru
detect
aptamerbas
viabil
impedimetr
sensor
virus
publish
labib
et
al
use
electrochemicalimped
spectroscopi
ei
detect
sensor
lod
pfu
vaccinia
viru
uniqu
featur
capac
distinguish
viabl
nonviabl
viru
particl
small
dynam
rang
pfu
assay
time
h
importantli
requir
temperatureregul
incub
made
method
less
suitabl
poct
solidst
nanopor
also
make
use
labelfre
electrochem
transduct
labelfre
realtim
detect
method
singl
interact
sensit
reli
format
complex
target
rna
aptam
measur
resistivepuls
techniqu
principl
techniqu
shown
detect
viru
nucleocapsid
protein
howev
main
applic
foreseen
character
relev
biomolecular
interact
rather
diagnost
tool
ruslinda
et
al
publish
diamond
fieldeffect
transistor
fet
base
aptasensor
detect
tat
protein
demonstr
stabl
reusabl
platform
poct
diamondfet
measur
bind
aptam
target
detect
chang
charg
distribut
diamond
surfac
gener
fetbas
sensor
simpl
fabric
miniatur
often
lead
fundament
problem
sens
capac
diamondfetbas
techniqu
scalabl
problem
overcom
show
potenti
handheld
devic
result
diamondfetbas
aptasensor
display
stabl
result
measur
tat
protein
clinic
matric
sensit
nm
impress
firsttim
result
suitabl
situat
abund
target
molecul
competitionbas
electrochemicaldetect
method
bionanogatebas
biosensor
measur
influenza
publish
wang
et
al
lactat
dehydrogenas
ldh
enzym
coat
glassycarbon
electrod
cover
gold
surfac
contain
bionanog
bionanog
bind
specif
aptam
present
therebi
block
access
substrat
immobil
ldh
enzym
howev
viral
presenc
aptam
interact
virion
leav
bionanog
open
induc
substrat
convers
substrat
convers
electrochem
measur
result
lod
hau
although
method
highli
sensit
use
ldh
signal
convers
greatli
influenc
type
clinic
matrix
ldh
present
human
tissu
aptamerfunction
conduct
polym
pedotoh
tso
microelectrod
publish
kiilerichpedersen
et
al
high
sensit
plaqueform
unit
pfu
influenza
per
ml
detect
detect
mechan
base
measur
chang
imped
virion
captur
immobil
aptam
polym
fluidic
devic
consist
four
layer
electrod
electr
connect
patch
pattern
pedotoh
tso
insert
circular
devic
mm
diamet
test
clinic
matrix
saliva
led
reduct
sensit
pfuml
still
well
within
relev
spectrum
viral
load
sinc
sampl
measur
absolut
interact
measur
low
pfu
summari
lowcost
manufactur
handheld
size
labelfre
high
sensit
assaytim
min
make
function
conduct
polym
aptasensor
promis
use
poct
sinc
discoveri
aptam
expect
clinic
applic
particular
diagnost
aptasensor
develop
high
howev
use
aptam
practic
still
rare
probabl
import
scientif
reason
relat
difficulti
select
highlyselect
aptam
wide
differ
target
measur
condit
recent
first
promis
aptasensor
made
debut
viral
diagnost
hope
increas
interest
diagnost
aptasensor
near
futur
user
paramet
turnround
time
less
min
portabl
robust
eas
use
fundament
requir
aptasensorbas
poct
howev
sensit
specif
select
well
quantit
multiplex
capac
depend
clinic
need
strong
demand
multiplex
diagnost
measur
pathogen
diseas
often
caus
coinfect
respect
sever
multiplex
pcr
method
develop
diagnosi
sepsi
respiratori
gastrointestin
infect
far
aptamerbas
applic
shown
potenti
multiplex
measur
mixtur
bacteria
howev
aptamerbas
detect
method
develop
measur
multipl
virus
therefor
import
defin
clearli
aspect
per
case
follow
iter
approach
continu
redefin
assay
requir
select
appropri
target
aptam
aptasensor
affect
develop
poct
fig
despit
seemingli
unlimit
possibl
improv
sens
technolog
ultim
goal
creat
accur
fast
afford
easytous
detect
system
suitabl
poct
abl
becom
standard
viral
diagnost
order
accomplish
goal
import
perform
compar
studi
use
differ
aptasensor
target
similar
virus
differ
matric
